FLUTICASONE FUROATE — all Canadian products
7 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is FLUTICASONE FUROATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02446561 | ARNUITY ELLIPTA | GLAXOSMITHKLINE INC | Powder | Oral; Inhalation | FLUTICASONE FUROATE 100 MCG | Marketed | |
| 02446588 | ARNUITY ELLIPTA | GLAXOSMITHKLINE INC | Powder | Oral; Inhalation | FLUTICASONE FUROATE 200 MCG | Marketed | |
| 02298589 | AVAMYS | GLAXOSMITHKLINE INC | Spray (Metered-Dose) | Nasal | FLUTICASONE FUROATE 27.5 MCG | Marketed | |
| 02444186 | BREO ELLIPTA | GLAXOSMITHKLINE INC | Powder | Inhalation | FLUTICASONE FUROATE 200 MCG; VILANTEROL (VILANTEROL TRIFENATATE) 25 MCG | Marketed | |
| 02408872 | BREO ELLIPTA | GLAXOSMITHKLINE INC | Powder | Inhalation | FLUTICASONE FUROATE 100 MCG; VILANTEROL (VILANTEROL TRIFENATATE) 25 MCG | Marketed | |
| 02515776 | TRELEGY ELLIPTA | GLAXOSMITHKLINE INC | Powder | Inhalation | FLUTICASONE FUROATE 200 MCG; UMECLIDINIUM (UMECLIDINIUM BROMIDE) 62.5 MCG; VILANTEROL (VILANTEROL TRIFENATATE) 25 MCG | Marketed | |
| 02474522 | TRELEGY ELLIPTA | GLAXOSMITHKLINE INC | Powder | Inhalation | FLUTICASONE FUROATE 100 MCG; UMECLIDINIUM (UMECLIDINIUM BROMIDE) 62.5 MCG; VILANTEROL (VILANTEROL TRIFENATATE) 25 MCG | Marketed |
Browse other molecules: